About Kiadis Pharma
Kiadis Pharma is a company based in Amsterdam (Netherlands) founded in 1997 was acquired by Sanofi in November 2020.. Kiadis Pharma has raised $32.95 million across 11 funding rounds from investors including Sanofi, Kreos Capital and Life Sciences Partners. Kiadis Pharma has completed 1 acquisition, including Cyto-Sen Therapeutics. Kiadis Pharma operates in a competitive market with competitors including Adicet Bio, Orca Bio, Ossium Health, Rubius Therapeutics and Auron Therapeutics, among others.
- Headquarter Amsterdam, Netherlands
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Kiadis Pharma
Kiadis Pharma has successfully raised a total of $32.95M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5.86 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $5.9M
-
First Round
First Round
(26 Jun 2007)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2020 | Amount | Post-IPO - Kiadis Pharma | Valuation |
investors |
|
| Apr, 2020 | Amount | Post-IPO - Kiadis Pharma | Valuation |
investors |
|
| Apr, 2020 | Amount | Post-IPO - Kiadis Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kiadis Pharma
Kiadis Pharma has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Sanofi, Kreos Capital and Life Sciences Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Founded Year | Domain | Location | |
|
Private equity investments in life sciences businesses are managed.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on healthcare companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kiadis Pharma
Kiadis Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cyto-Sen Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
NK cell therapies are developed for acute myeloid leukemia treatment.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Kiadis Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kiadis Pharma Comparisons
Competitors of Kiadis Pharma
Kiadis Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adicet Bio, Orca Bio, Ossium Health, Rubius Therapeutics and Auron Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Immune cell therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| domain | founded_year | HQ Location |
Ossium Health is focused on bioengineering for improved health.
|
|
| domain | founded_year | HQ Location |
Genetically modifying hematopoietic stem cells to create RBC therapeutics in metabolic deficiencies, autoimmune disorders, and cancer
|
|
| domain | founded_year | HQ Location |
Developer of cancer therapeutics for the treatment of blood cancer
|
|
| domain | founded_year | HQ Location |
Antibody radionuclide conjugates are developed for haematological cancers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kiadis Pharma
Frequently Asked Questions about Kiadis Pharma
When was Kiadis Pharma founded?
Kiadis Pharma was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Where is Kiadis Pharma located?
Kiadis Pharma is headquartered in Amsterdam, Netherlands.
Is Kiadis Pharma a funded company?
Kiadis Pharma is a funded company, having raised a total of $32.95M across 11 funding rounds to date. The company's 1st funding round was a Post-IPO of $13M, raised on Jun 26, 2007.
What does Kiadis Pharma do?
Founded in 1997 and based in Amsterdam, Netherlands, Kiadis Pharma operates in the biotechnology sector, focusing on solutions for complications in hematopoietic stem cell transplants for blood cancer patients. Allodepleted T-cell immunotherapeutics (ATIR) are utilized to bolster the patients immune system post-transplant, facilitating acceptance from haploidentical or lower-matched donors. Investigations into ATIR applications for leukemia and thalassemia are ongoing.
Who are the top competitors of Kiadis Pharma?
Kiadis Pharma's top competitors include Orca Bio, Ossium Health and Adicet Bio.
How many acquisitions has Kiadis Pharma made?
Kiadis Pharma has made 1 acquisition, including Cyto-Sen Therapeutics.
Who are Kiadis Pharma's investors?
Kiadis Pharma has 8 investors. Key investors include Sanofi, Kreos Capital, Life Sciences Partners, NVNOM, and Draper Esprit.